Literature DB >> 20833389

Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion.

Xiaoyan Yin1, Kuldeepsinh Rana, Varun Ponmudi, Michael R King.   

Abstract

Adhesive interactions between selectins and their ligands play an essential role during cancer extravasation. Fucosylation of these proteins by fucosyltransferases, or FUTs, is critical for their functions. Using quantitative RT-PCR, we demonstrated that FUT4 and FUT7 are the predominant FUTs expressed in hematopoietic cell line, while FUT3 is heavily expressed by multiple cancer cell lines including the prostate cancer cell line MDA PCa2b. Knockdown of FUT3 expression in MDA PCa2b cells by small interference RNA (siRNA) significantly reduced FUT3 expression. Cell-surface sialyl Lewis antigens were largely abolished. Cell adhesion and cell rolling on the blood vessel wall were simulated by perfusing cancer cells through microtubes coated with recombinant human E-selectin. At physiological levels of wall shear stress, the number of flowing cancer cells recruited to the microtube surface was dramatically reduced by FUT3 knockdown. Higher rolling velocity was also observed, which is consistent with reduced E-selectin binding activity. Interestingly, FUT3 siRNA treatment also significantly reduced the cell growth rate. Combined with the novel siRNA delivery platform recently developed in our laboratory, FUT3 siRNA could be a promising conjunctive therapy aiming at reducing the metastatic virulence of circulating epithelial cancer cells.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833389      PMCID: PMC2995892          DOI: 10.1016/j.carres.2010.07.028

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  52 in total

1.  Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

Authors:  M B Lawrence; T A Springer
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

2.  The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis.

Authors:  P Malý; A Thall; B Petryniak; C E Rogers; P L Smith; R M Marks; R J Kelly; K M Gersten; G Cheng; T L Saunders; S A Camper; R T Camphausen; F X Sullivan; Y Isogai; O Hindsgaul; U H von Andrian; J B Lowe
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

3.  Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking.

Authors:  Steven R Barthel; Georg K Wiese; Jaehyung Cho; Matthew J Opperman; Danielle L Hays; Javed Siddiqui; Kenneth J Pienta; Bruce Furie; Charles J Dimitroff
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-04       Impact factor: 11.205

4.  Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials.

Authors:  R Sawada; S Tsuboi; M Fukuda
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

5.  Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin.

Authors:  Charles J Dimitroff; Mirna Lechpammer; Denise Long-Woodward; Jeffery L Kutok
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

6.  Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues.

Authors:  K M Schweitzer; A M Dräger; P van der Valk; S F Thijsen; A Zevenbergen; A P Theijsmeijer; C E van der Schoot; M M Langenhuijsen
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

7.  Expression of alpha-1,3-fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer.

Authors:  J Ogawa; H Inoue; S Koide
Journal:  Cancer Res       Date:  1996-01-15       Impact factor: 12.701

8.  Up-regulation of the oligosaccharide sialyl LewisX: a new prognostic parameter in metastatic prostate cancer.

Authors:  T Jørgensen; A Berner; O Kaalhus; K J Tveter; H E Danielsen; M Bryne
Journal:  Cancer Res       Date:  1995-05-01       Impact factor: 12.701

9.  Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells.

Authors:  Y Izumi; Y Taniuchi; T Tsuji; C W Smith; S Nakamori; I J Fidler; T Irimura
Journal:  Exp Cell Res       Date:  1995-01       Impact factor: 3.905

10.  P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin.

Authors:  K L Moore; K D Patel; R E Bruehl; F Li; D A Johnson; H S Lichenstein; R D Cummings; D F Bainton; R P McEver
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

View more
  22 in total

1.  Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes.

Authors:  Michael J Mitchell; Carlos A Castellanos; Michael R King
Journal:  J Nanomater       Date:  2012       Impact factor: 2.986

2.  Surfactant functionalization induces robust, differential adhesion of tumor cells and blood cells to charged nanotube-coated biomaterials under flow.

Authors:  Michael J Mitchell; Carlos A Castellanos; Michael R King
Journal:  Biomaterials       Date:  2015-04-17       Impact factor: 12.479

3.  E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells.

Authors:  Michael J Mitchell; Christina S Chen; Varun Ponmudi; Andrew D Hughes; Michael R King
Journal:  J Control Release       Date:  2012-03-01       Impact factor: 9.776

4.  Immobilized surfactant-nanotube complexes support selectin-mediated capture of viable circulating tumor cells in the absence of capture antibodies.

Authors:  Michael J Mitchell; Carlos A Castellanos; Michael R King
Journal:  J Biomed Mater Res A       Date:  2015-03-30       Impact factor: 4.396

5.  In vitro method to observe E-selectin-mediated interactions between prostate circulating tumor cells derived from patients and human endothelial cells.

Authors:  Gunjan Gakhar; Neil H Bander; David M Nanus
Journal:  J Vis Exp       Date:  2014-05-15       Impact factor: 1.355

6.  Comparing the Immunoexpression of FUT3 and FUT6 between Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia.

Authors:  Juliana Lúcia de Albuquerque Vasconcelos; Steffany de Almeida Ferreira; Amanda Lucena Rosendo de Lima; Moacyr Jesus Barreto de Melo Rêgo; Ana Rosa Galdino Bandeira; Carmelita de Lima Bezerra Cavalcanti; Mariana Montenegro de Melo Lira; Eduardo Isidoro Carneiro Beltrão
Journal:  Acta Histochem Cytochem       Date:  2013-06-20       Impact factor: 1.938

7.  Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable stage III colorectal adenocarcinomas.

Authors:  Venkat R Katkoori; Chandrakumar Shanmugam; Xu Jia; Swaroop P Vitta; Meenakshi Sthanam; Tom Callens; Ludwine Messiaen; Dongquan Chen; Bin Zhang; Harvey L Bumpers; Temesgen Samuel; Upender Manne
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

Review 8.  L-fucose, a sugary regulator of antitumor immunity and immunotherapies.

Authors:  Emma Adhikari; Qian Liu; Chase Burton; Andrea Mockabee-Macias; Daniel K Lester; Eric Lau
Journal:  Mol Carcinog       Date:  2022-02-02       Impact factor: 5.139

9.  Adhesion receptors as therapeutic targets for circulating tumor cells.

Authors:  Jiahe Li; Michael R King
Journal:  Front Oncol       Date:  2012-07-24       Impact factor: 6.244

10.  Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesion.

Authors:  Yue Geng; Siddarth Chandrasekaran; Jong-Wei Hsu; Mishka Gidwani; Andrew D Hughes; Michael R King
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.